Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Mol Pharm. 2019 Feb 25;16(4):1694–1702. doi: 10.1021/acs.molpharmaceut.9b00025

Figure 4.

Figure 4.

Representative maximum intensity projection SPECT/CT images of B16/F1 (A) and B16/F10 (B) flank melanoma-bearing C57 mice, maximum intensity projection SPECT/CT and coronal images of B16/F10 pulmonary metastatic melanoma-bearing (C, D) C57 mice using 203Pb-DOTA-GGNle-CycMSHhex as an imaging probe at 2 h post-injection.